René C. Bakker

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cushing’s syndrome complicated by multiple opportunistic infections

René C. Bakker, Pierre Gallas, J. A. Romijn et al. · Journal of Endocrinological Investigation · 1998 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +12

Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy

René C. Bakker, A. A. M. J. Hollander, Marko J.K. Mallat et al. · Kidney International · 2003 · 54 citations · Full text

Medicine, Nephrology, Pharmacotherapy +12

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17